Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
P3-091: A Phase I study of continuous oral...
Journal article

P3-091: A Phase I study of continuous oral treatment with the triple angiokinase inhibitor BIBF 1120 together with pemetrexed in previously treated patients with non-small cell lung cancer

Authors

Hanna N; Ellis P; Stopfer P; Shapiro D; Gyorffy S

Journal

Journal of Thoracic Oncology, Vol. 2, No. 8, pp. s717–s718

Publisher

Elsevier

Publication Date

August 2007

DOI

10.1097/01.jto.0000284067.45483.01

ISSN

1556-0864